Results 91 to 100 of about 14,767 (273)

Microfluidics‐Based Microcarriers for Live‐Cell Delivery

open access: yesAdvanced Science, EarlyView.
In this review, recent advancements in microfluidics‐based microcarriers for live‐cell delivery are highlighted. The structural designs of microfluidic‐derived cell‐laden microcarriers are systematically categorized, emphasizing innovative approaches in the fabrication of microspheres, microfibers, and microneedles.
Zhonglin Fang   +3 more
wiley   +1 more source

Chemically Enhanced Immunogenicity of Bacteria by Supramolecular Functionalization with an Adjuvant

open access: yesChemBioChem, Volume 23, Issue 23, December 5, 2022., 2022
Poorly immunogenic pathogens are a major cause of infectious disease. We chemically modified the surface of such a pathogen (Staphylococcus aureus) with a synthetic adjuvant to boost immunogenicity. “Adjuvanted” S. aureus induced improved immune responses in macrophages compared to unadulterated bacteria.
Nikolas Duszenko   +5 more
wiley   +1 more source

In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor

open access: yesBioengineering, 2017
Subunit vaccines often require adjuvants to elicit sustained immune activity. Here, a method is described to evaluate the efficacy of single vaccine candidates in the preclinical stage based on cytokine and gene expression analysis.
Lars Radke   +11 more
doaj   +1 more source

Engineering the Immune Response to Biomaterials

open access: yesAdvanced Science, EarlyView.
This paper reviews immune responses to biomaterials, stages of evolution in relation to managing these responses ranging from preventing to modulating them. It also discusses state‐of‐the‐art strategies to modulate these responses and modes of their delivery.
Abolfazl Salehi Moghaddam   +12 more
wiley   +1 more source

Randomized preclinical study of machine perfusion in vascularized composite allografts

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
This study was designed to identify the optimum machine perfusion parameters for preservation of limbs before transplantation, and determine whether this was better than cold storage. Normothermic machine perfusion at a pressure of 70 mmHg (NMP‐70) provided superior preservation to cold storage after transplantation.
K. R. Amin   +7 more
wiley   +1 more source

JAK Inhibitor Clinical Response in Polyarthritis: Case Report

open access: yesActa Clinica Croatica, 2015
The heterogeneity of rheumatoid arthritis (RA) presentation and molecular signature of RA subclasses in patients with early changes of small peripheral joints still remains a challenging problem.
Asja Stipić-Marković   +5 more
doaj  

Reprogramming the Tumor Immune Microenvironment with ICAM‐1‐Targeted Antibody‒Drug Conjugates and B7‐H3‐CD3 Bispecific Antibodies

open access: yesAdvanced Science, EarlyView.
Reprogramming the tumor immune microenvironment is crucial for transforming immune “cold” tumors into “hot” inflammatory tumors. The investigation reveals that the combination of ICAM‐1‐Dxd with B7‐H3‐CD3 bispecific antibodies not only demonstrates significant inhibitory effects on tumor growth and metastasis but also plays a vital role in ...
Shoubing Zhou   +9 more
wiley   +1 more source

Summary of the primer on tumor immunology and the biological therapy of cancer

open access: yesJournal of Translational Medicine, 2009
The International Society for Biological Therapy of Cancer (iSBTc) is one of the "premier destinations for interaction and innovation in the cancer biologics community".
Margolin Kim   +3 more
doaj   +1 more source

SIMMUNE, a tool for simulating and analyzing immune system behavior [PDF]

open access: yesarXiv, 1999
We present a new approach to the simulation and analysis of immune system behavior. The simulations that can be done with our software package called SIMMUNE are based on immunological data that describe the behavior of immune system agents (cells, molecules) on a microscopial (i.e.
arxiv  

KK2DP7 Stimulates CD11b+ Cell Populations in the Spleen to Elicit Trained Immunity for Anti‐Tumor Therapy

open access: yesAdvanced Science, EarlyView.
This study introduces KK2DP7, a dendrimer‐structured peptide adjuvant, as a tool to decode trained immunity's role in antitumor therapy. Splenic CD11b+ cells mediate tumor suppression via TLR2‐IRF7 activation and epigenetic reprogramming, validated by adoptive transfer experiments.
Rui Zhang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy